WeedLife News Network

Lack of proper sleep can have adverse affect on your body and overall well-being. The good news is, cannabis can help, to a certain extent.

A few months ago the Food and Drug Administration (FDA) made waves by approving a cannabis-based medication for the first time ever. And now that medication is finally available to the public.

Cannabis kills brain cancer cells in petri dishes so Australian researchers are embarking on a clinical trial to determine if it kills those cells in live patients too.

A new medical cannabis company called Katexco Pharmaceuticals aims to develop oral therapies that harness the brain’s endocannabinoid and nicotine receptors to treat inflammatory diseases such as multiple sclerosis.

Trying to keep track of all the advances in cannabis research? Here are some brief summaries from some of the biggest headlines of the fall.

Many sickle cell disease (SCD) patients use marijuana for its medicinal benefits, according to an anonymous survey by researchers from Yale New Haven Hospital and Yale University.

The Rhode Island Department of Health approved a petition from parents Tuesday which would allow them to use medical marijuana to treat children with autism.

Two Israeli medical cannabis companies announced entering a strategic partnership to co-found development and clinical validation of a range of cannabis-based ADHD products.

“It’s just a different marijuana than what was easily available ten years ago. And when you have a stronger drug, you have stronger drug effects.”

Tears streamed down Jana Adams’ face Friday when her attorney delivered the news by phone that her 5-year-old daughter, Brooke, can continue attending public elementary school — and bring with her the cannabis-based medication she needs.

Merry Jane spoke with doctors, people living with endometriosis, and creators of cannabis wellness products to learn how the plant can provide real relief for the complex ailment.

A majority of physicians are in favor of legalizing marijuana nationwide, according to a newly published survey, and an even bigger supermajority back allowing medical cannabis.

Cannabidiol reduces the brain activity linked to hallucinations, delusions and other forms of psychosis, research has found.

Scientists are also looking for way to suppress or modulate inappropriate brain signals, spurring development of new drugs with novel brain targets, such as cannabinoid receptors.

This mechanism has potential to be therapeutically exploited."

In a release issued Thursday by Gov. Ricardo Rosselló’s office, La Fortaleza, it was announced that an online platform “that seeks to significantly streamline the licensing processes and the registration of patients who benefit from the Medicinal Cannabis Program” will be fully operational next week.

A new clinical trial involving medical marijuana is seeing one patient with multiple sclerosis walking with strength she hasn't had in years.

About 30,000 people in Illinois are approved for medical marijuana, but not everyone wants to smoke it. A cooking class in the northern suburbs is teaching patients how to cook with cannabis.

The latest in a string of studies to demonstrate a link between medical marijuana legalization and lower opioid use rates has just been released.

In America, more people are diagnosed with Lyme disease annually than HIV and breast cancer combined.